Funding Opportunity PAR-24-087 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi site clinical trial (Phase III and beyond) application submitted under companion PAR-21-243. The DCC application must be specific to the companion Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH. Trials for which this NOFO applies must be relevant to the research mission of NCCIH and considered a high priority by the Center. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website (http://www.nccih.nih.gov). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Funding Opportunity PAR-24-086 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of complementary and integrative health interventions in NCCIH- designated areas of high research priority. Applications submitted under this NOFO are expected to propose a remotely delivered and conducted fully powered clinical trial with no in-person contact between research staff and study participants and may utilize mHealth tools or technologies. Applicants must provide justification for the remotely delivered approach and provide preliminary data on the feasibility and safety of the approach, along with evidence that the intervention has promise of clinical benefit. Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Funding Opportunity PAR-24-083 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this NOFO are expected to propose a multisite feasibility clinical trial that will provide new information that is scientifically necessary for the planning and conduct of a subsequent clinical efficacy or effectiveness study, pragmatic trial, or dissemination and implementation trial within NCCIHs mission. NCCIH expects that applications to this NOFO will describe the planned future clinical trial and in so doing demonstrate that the proposed (R01) research is scientifically necessary to design or plan the subsequent fully powered, full-scale clinical trial. Under this R01, the data collected should be used to fill gaps in scientific knowledge, including, but not limited to the following: assessing whether the intervention can be delivered with fidelity across sites; demonstrating feasibility of recruitment, accrual, and randomization of participants across sites; demonstrating participant adherence to the intervention, as well as retention of participants throughout the study across sites; refining and assessing the feasibility of protocolized multimodal interventions, and/or demonstrating feasibility of data collection across sites in preparation for a future fully powered, multisite efficacy or effectiveness trial. The need for multisite feasibility trials is expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s) or the published literature. The data collected should be used to fill gaps in scientific knowledge and be necessary to develop a competitive fully powered multisite clinical trial that has the potential to make a significant impact on public health.

Notice NOT-CA-24-023 from the NIH Guide for Grants and Contracts

Notice NOT-DK-24-007 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-022 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-048 from the NIH Guide for Grants and Contracts

Notice NOT-HG-24-012 from the NIH Guide for Grants and Contracts

F. Hoffmann-La Roche AG: As a member of the AI, Data and Digital (AIDD) team, you will partner with research scientists and data experts at China Innovation Center of Roche... Shanghai, China

Notice NOT-MH-24-140 from the NIH Guide for Grants and Contracts

Negotiable: SRG: We are in search of a creative and self-driven individual who possesses a deep understanding of in-silico drug discovery chemistry techniques and principles. Additionally, strong leadership skills are essential for building and overseeing a new team. Cambridge, England

Negotiable: AstraZeneca : Do you have expertise in algorithm development and computer sciences? Would you like to apply your expertise in image analysis / artificial intellige Munich, Germany

Notice NOT-AR-23-024 from the NIH Guide for Grants and Contracts

Notice NOT-EB-23-024 from the NIH Guide for Grants and Contracts

Notice NOT-DE-24-007 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-315 from the NIH Guide for Grants and Contracts. The overarching goal of this PAR is to support educational activities that complement and/or enhance the training of the clinical and research workforce, and bring awareness of Geroscience to members of the public, by supporting creative educational activities with a primary focus on the development and integration of basic, applied, translational, and clinical topics in Geroscience including: Curriculum or Methods Development, Courses for Skills Development, Research Experiences and Networking, Development of a Repository of Important Reviews and Opinion Pieces and Clinical Trials in Progress, Outreach and Creation of Lay Public Documents on Geroscience.

Notice NOT-HL-23-125 from the NIH Guide for Grants and Contracts

Notice NOT-DK-24-005 from the NIH Guide for Grants and Contracts

Notice NOT-DK-24-004 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-033 from the NIH Guide for Grants and Contracts